
Opinion|Videos|March 21, 2024
Challenges in Treating High-Risk Patients With Diabetes
Estay Greene, PharmD, MBA, outlines the main barriers that need to be addressed from a payer perspective in the treatment of high-risk patients with diabetes.
Advertisement
Episodes in this series

Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FAQ: The uncertain future of enhanced ACA premium subsidies and what it means for U.S. healthcare
2
Myqorzo is now available for rare heart condition at a $108,400 annual price
3
Medicaid tech companies pledge $600 million to help states update systems
4
Why the great pharma-MedTech divide is healthcare’s biggest miss
5























